Page last updated: 2024-10-25

clofibrate and Leigh Disease

clofibrate has been researched along with Leigh Disease in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Leigh Disease: A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. (From Menkes, Textbook of Child Neurology, 5th ed, p850).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Frambach, SJCM1
van de Wal, MAE1
van den Broek, PHH1
Smeitink, JAM1
Russel, FGM1
de Haas, R1
Schirris, TJJ1

Other Studies

1 other study available for clofibrate and Leigh Disease

ArticleYear
Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice.
    Biochimica et biophysica acta. Molecular basis of disease, 2020, 06-01, Volume: 1866, Issue:6

    Topics: Adenosine Triphosphate; Animals; Bezafibrate; Chromans; Clofibrate; Electron Transport Complex I; Fa

2020